Position in UTHR
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$60,319,766
-$5,601,227 QoQ
Shares Held
111,326
+0.1% QoQ
Ownership
0.260%
of shares outstanding
% of Portfolio
0.29%
of 13F equity value
Holder Rank
#65
of 870 holders
Holding Since
Jun 2022
17 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in UTHR Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Bridgewater Associates, LP holds $207,447,311 across 14 Drug Manufacturers - Specialty & Generic names. UTHR ranks #1 (29.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | UTHR |
UNITED THERAPEUTICS Corp
This page
|
111,326 | $60,319,766 | |
| 2 | TEVA |
Teva Pharmaceutical Industries Ltd
|
1,326,678 | $44,947,850 | |
| 3 | NBIX |
Neurocrine Biosciences Inc
|
205,677 | $34,664,801 | |
| 4 | VTRS |
Viatris Inc
|
1,698,341 | $26,969,655 | |
| 5 | ZTS |
Zoetis Inc.
|
134,203 | $9,643,827 | |
| 6 | LNTH |
Lantheus Holdings, Inc.
|
65,941 | $7,315,494 | |
| 7 | BCRX |
Biocryst Pharmaceuticals Inc
|
491,057 | $4,910,570 | |
| 8 | BHC |
Bausch Health Companies Inc.
|
866,285 | $4,270,785 |
All Filings in UTHR
Export CSV
17 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $60,319,766 | 111,326 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $65,920,993 | 111,169 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $31,473,913 | 64,595 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $6,734,608 | 16,065 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $56,067,157 | 195,118 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $59,737,793 | 193,784 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $38,011,453 | 107,730 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $22,129,904 | 61,755 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $4,062,149 | 12,752 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $1,826,274 | 7,950 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $1,983,187 | 9,019 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $4,098,862 | 18,147 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $9,007,703 | 40,805 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $9,241,709 | 41,265 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $6,981,171 | 25,104 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $9,258,155 | 44,217 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $12,824,942 | 54,426 | Shares | Sole | 2022-08-11 | |
| No filing history on record for this holder in this stock. | ||||||